Internal Medicine, Hematology & Oncology · Cleveland, OH
NPI
1013199058
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
9500 Euclid Avenue, Taussig Cancer Center -R35 - Cleveland Clinic
Cleveland, OH, 44195
Phone (216) 445-9451
Groups this clinician bills Medicare through
Medicare paid, 2024
$57K
990 services
Medicare patients, 2024
278
Average age 73
Drug cost, 2024
$6.7M
821 prescriptions
Company payments, 2025
$55K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brian T Hill was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 314 times for 194 patients. In total Brian T Hill billed 990 services in 18 codes, and Medicare paid $57K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-07.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 314 | 194 | $12.37 | $3,884 |
| 99215 Office E&M - Established | Facility | 212 | 106 | $97.42 | $21K |
| 99233 Hospital E&M - Subsequent | Facility | 146 | 44 | $88.73 | $13K |
| 99214 Office E&M - Established | Facility | 125 | 101 | $66.66 | $8,333 |
| 99213 Office E&M - Established | Facility | 92 | 85 | $43.26 | $3,980 |
| 99214 Office E&M - Established | Office | 24 | 21 | $86.88 | $2,085 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 14 | 13 | $11.60 | $162 |
| 99238 Hospital Discharge Management | Facility | 12 | 12 | $55.87 | $670 |
| 99213 Office E&M - Established | Office | 11 | 11 | $68.24 | $751 |
By year: 2022 $50K for 580 services; 2023 $55K for 685 services; 2024 $57K for 990 services.
Medicare prescription drug claims, 2024
In 2024, the drug Brian T Hill prescribed most often to Medicare patients was Calquence (Acalabrutinib Maleate), with 197 prescriptions and refills. In total Brian T Hill wrote 821 Medicare prescriptions that cost $6.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Calquence Acalabrutinib Maleate | 197 | 197 | 23 | $2.7M |
| Acyclovir Generic | 164 | 273 | 40 | $2,294 |
| Brukinsa Zanubrutinib | 72 | 72 | Under 11 | $811K |
| Jaypirca Pirtobrutinib | 71 | 71 | 11 | $1.4M |
| Venclexta Venetoclax | 64 | 64 | Under 11 | $755K |
| Imbruvica Ibrutinib | 34 | 34 | Under 11 | $601K |
| Prednisone Generic | 30 | 38 | 18 | $74.5 |
| Dexamethasone Generic | 16 | 16 | Under 11 | $179 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 15 | 17 | Under 11 | $17.44 |
| Ondansetron Hcl Generic | 15 | 15 | 12 | $1,200 |
| Tazverik Tazemetostat Hydrobromide | 13 | 13 | Under 11 | $228K |
Brand drugs: 478 claims; generic drugs: 343 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brian T Hill $55K ($55K in general payments such as food, travel and fees) from 11 companies. The largest payer was Kite Pharma, Inc. with $25K.
| Company | Payments | Amount |
|---|---|---|
| Kite Pharma, Inc. GILD | 19 | $25K |
| Abbvie Inc. ABBV | 19 | $12K |
| Incyte Corporation INCY | 13 | $8,781 |
| Genentech USA, Inc. ROG.SW | 3 | $5,463 |
| BeiGene USA, Inc. ONC | 1 | $2,400 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $1,690 |
| Adc Therapeutics America, Inc. | 3 | $303 |
| Genmab U.S., Inc. GMAB | 2 | $115 |
| Celgene Corporation BMY | 2 | $75.8 |
| BeOne Medicines USA, Inc. ONC | 1 | $30.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.